• SearchField_GetLegal

Actos

Pioglitazone, a prescription drug sold under the trade name Actos, is a pharmaceutical product proven to lower blood sugar levels in persons with Type 2 diabetes. It has also been used in experiments to treat persons with fatty liver.

In 2007, the manufacturer of the drug, Takeda Pharmaceutical Company, acknowledged that Pioglitazone had been tied to increased risk of bone fracture in females. Studies also show that Actos can cause fluid retention and risk of peripheral edema, may hasten the development of congestive heart failure, and may cause anemia. Users have also experienced weight gain, respiratory tract infections, headaches and sinus conditions, and toothaches.

In 2011, officials in France took Pioglitazone off the market because of concerns that there was a high risk of bladder cancer associated with the drug. The U.S. Food and Drug Administration (FDA) warned users that same year that use of Pioglitazone for more than one year could increase risk of bladder cancer.

If you or someone you love has suffered injury after taking Actos, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Connect with Top-rated Attorneys Near You

    Latest Article

    Videos

        GETLEGAL®ATTORNEY DIRECTORY

        Find Leading Attorneys in Your Area

            NEED PROFESSIONAL HELP?

            Talk to an Attorney

            How It Works

            • Briefly tell us about your case
            • Provide your contact information
            • Choose attorneys to contact you
            • SearchField_GetLegal

            ABOUT GETLEGAL

            Our mission at GetLegal is to develop a family of sites that constitute the most useful, informative, reliable and exciting collection of legal resources on the web. We are constantly working to expand and improve many resources we offer to legal professionals and the public.

            Contact Us : 817-359-7077

            RECENT TWEETS

            NEWSLETTER SIGN-UP

            By submitting information to this site, you give permission to GetLegal, or a partner of GetLegal, to contact you by email.

            Advertise With Us

            © 2008-2021 LawConnect, Inc. All rights reserved. Sitemap | Copyright/DMCA Policy | Privacy Policy | Terms of Use | Disclosures/Disclaimers